심장 캐뉼라 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 재료별, 사이즈별, 연령층별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Cardiac Cannula Market Summary

The global cardiac cannula market size was valued at USD 271.88 million in 2025 and is projected to reach USD 447.20 million by 2033, growing at a CAGR of 6.45% from 2026 to 2033. The market is driven by the rising prevalence of cardiovascular diseases and the increasing volume of cardiac surgeries worldwide.

The growing adoption of minimally invasive and robotic-assisted procedures, along with the expansion of advanced cardiac care services, is driving demand for high-performance cannulas. Furthermore, the need for reliable extracorporeal circulation during complex interventions, along with advancements in cannula design and materials, is further fueling market growth.

The increasing volume of cardiac surgeries is driving the global market by increasing demand for essential surgical tools used in these procedures. As more patients undergo interventions such as bypass surgeries, valve replacements, and heart transplants, hospitals and cardiac centers require reliable, efficient cannulas to ensure optimal blood flow and patient safety. This growing procedural demand directly fuels market expansion and innovation in cannula technologies.

Global Cardiac Cannula Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global cardiac cannula market report on the basis of product, application, material, size, age group, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Arterial Cannulas
• Venous Cannulas
• Cardioplegia Cannulas
• Specialty Cannulas
• Application Outlook (Revenue, USD Million; 2021 - 2033)
• Cardiopulmonary Bypass (CPB)
• Minimally Invasive & Robotic Surgery (MICS)
• Extracorporeal Membrane Oxygenation (ECMO)
• Material Outlook (Revenue, USD Million; 2021 - 2033)
• Silicone
• Polyurethane
• Polyvinyl Chloride (PVC)
• Size Outlook (Revenue, USD Million; 2021 - 2033)
• 4 Fr - 7 Fr
• 8 Fr - 10 Fr
• 11 Fr - 22 Fr
• 23 Fr - 36 Fr
• 36+ Fr
• Age Group Outlook (Revenue, USD Million; 2021 - 2033)
• Adults
• Pediatric
• End-use Outlook (Revenue, USD Million; 2021 - 2033)
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. Material
  • 1.1.4. Size
  • 1.1.5. Age Group
  • 1.1.6. End Use
  • 1.1.7. Regional scope
  • 1.1.8. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Cannula Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing volume of cardiac surgeries
    • 3.2.1.2. Growing adoption of Extracorporeal Membrane Oxygenation (ECMO)
    • 3.2.1.3. Expansion of advanced cardiac services
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High Cost of Devices
    • 3.2.2.2. Product Recalls
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Rising shift toward minimally invasive and robotic-assisted cardiac procedures
    • 3.2.3.2. Expansion of pediatric and specialized cannulas
    • 3.2.3.3. Increasing number of clinical trials
    • 3.2.3.4. Technological innovation in cannula design
    • 3.2.3.5. Strategic partnerships and distribution expansion
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Regulatory challenges
    • 3.2.4.2. Limited skilled professionals
• 3.3. Cardiac Cannula Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Cardiac Cannula Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cardiac Cannula Market: Product Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Cardiac Cannula Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Arterial Cannulas
  • 4.4.1. Arterial cannulas market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Venous Cannulas
  • 4.5.1. Venous cannulas market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Cardioplegia Cannulas
  • 4.6.1. Cardioplegia cannulas market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Specialty Cannulas
  • 4.7.1. Specialty cannulas market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cardiac Cannula Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cardiac Cannula Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Cardiac Cannula Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
• 5.4. Cardiopulmonary Bypass (CPB)
  • 5.4.1. Cardiopulmonary bypass (CPB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Minimally Invasive & Robotic Surgery (MICS)
  • 5.5.1. Minimally invasive & robotic surgery (MICS) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Extracorporeal Membrane Oxygenation (ECMO)
  • 5.6.1. Extracorporeal membrane oxygenation (ECMO) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cardiac Cannula Market: Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Cardiac Cannula Market: Material Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Cardiac Cannula Market Size & Trend Analysis, by Material 2021 to 2033 (USD Million)
• 6.4. Silicone
  • 6.4.1. Silicone market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Polyurethane
  • 6.5.1. Polyurethane market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Polyvinyl Chloride (PVC)
  • 6.6.1. Polyvinyl chloride (PVC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cardiac Cannula Market: Size Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Cardiac Cannula Market: Size Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Cardiac Cannula Market Size & Trend Analysis, by Size 2021 to 2033 (USD Million)
• 7.4. 4 Fr - 7 Fr
  • 7.4.1. 4 Fr - 7 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. 8 Fr - 10 Fr
  • 7.5.1. 8 Fr - 10 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. 11 Fr - 22 Fr
  • 7.6.1. 11 Fr - 22 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. 23 Fr - 36 Fr
  • 7.7.1. 23 Fr - 36 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. 36+ Fr
  • 7.8.1. 36+ Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cardiac Cannula Market: Age Group Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Cardiac Cannula Market: Age Group Movement Analysis, 2025 & 2033 (USD Million)
• 8.3. Global Cardiac Cannula Market Size & Trend Analysis, by Age Group 2021 to 2033 (USD Million)
• 8.4. Adults
  • 8.4.1. Adults market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Pediatric
  • 8.5.1. Pediatric market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Cardiac Cannula Market: End Use Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Global Cardiac Cannula Market: End use Movement Analysis, 2025 & 2033 (USD Million)
• 9.3. Global Cardiac Cannula Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
• 9.4. Hospitals
  • 9.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Specialty Clinics
  • 9.5.1. Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Ambulatory Surgical Centers
  • 9.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. Others
  • 9.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Cardiac Cannula Market: Regional Estimates & Trend Analysis by Product, Application, Material, Size, Age Group and End Use

• 10.1. Regional Dashboard
• 10.2. Market Size and Trend Analysis, 2021 to 2033
• 10.3. North America
  • 10.3.1. North America cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.3.2. U.S.
    • 10.3.2.1. Key country dynamics
    • 10.3.2.2. Competitive scenario
    • 10.3.2.3. Regulatory framework
    • 10.3.2.4. Reimbursement scenario
    • 10.3.2.5. U.S. cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.3.3. Canada
    • 10.3.3.1. Key country dynamics
    • 10.3.3.2. Competitive scenario
    • 10.3.3.3. Regulatory framework
    • 10.3.3.4. Reimbursement scenario
    • 10.3.3.5. Canada cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.3.4. Mexico
    • 10.3.4.1. Key country dynamics
    • 10.3.4.2. Competitive scenario
    • 10.3.4.3. Regulatory framework
    • 10.3.4.4. Reimbursement scenario
    • 10.3.4.5. Mexico cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.4. Europe
  • 10.4.1. Europe cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.2. UK
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Competitive scenario
    • 10.4.2.3. Regulatory framework
    • 10.4.2.4. Reimbursement scenario
    • 10.4.2.5. UK cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.3. Germany
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. Competitive scenario
    • 10.4.3.3. Regulatory framework
    • 10.4.3.4. Reimbursement scenario
    • 10.4.3.5. Germany cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.4. France
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Competitive scenario
    • 10.4.4.3. Regulatory framework
    • 10.4.4.4. Reimbursement scenario
    • 10.4.4.5. France cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.5. Italy
    • 10.4.5.1. Key country dynamics
    • 10.4.5.2. Competitive scenario
    • 10.4.5.3. Regulatory framework
    • 10.4.5.4. Reimbursement scenario
    • 10.4.5.5. Italy cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.6. Spain
    • 10.4.6.1. Key country dynamics
    • 10.4.6.2. Competitive scenario
    • 10.4.6.3. Regulatory framework
    • 10.4.6.4. Reimbursement scenario
    • 10.4.6.5. Spain cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.7. Sweden
    • 10.4.7.1. Key country dynamics
    • 10.4.7.2. Competitive scenario
    • 10.4.7.3. Regulatory framework
    • 10.4.7.4. Reimbursement scenario
    • 10.4.7.5. Sweden cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.8. Denmark
    • 10.4.8.1. Key country dynamics
    • 10.4.8.2. Competitive scenario
    • 10.4.8.3. Regulatory framework
    • 10.4.8.4. Reimbursement scenario
    • 10.4.8.5. Denmark cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.9. Norway
    • 10.4.9.1. Key country dynamics
    • 10.4.9.2. Competitive scenario
    • 10.4.9.3. Regulatory framework
    • 10.4.9.4. Reimbursement scenario
    • 10.4.9.5. Norway cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Asia Pacific cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.2. China
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. Competitive scenario
    • 10.5.2.3. Regulatory framework
    • 10.5.2.4. Reimbursement scenario
    • 10.5.2.5. China cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.3. Japan
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. Competitive scenario
    • 10.5.3.3. Regulatory framework
    • 10.5.3.4. Reimbursement scenario
    • 10.5.3.5. Japan cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.4. India
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Competitive scenario
    • 10.5.4.3. Regulatory framework
    • 10.5.4.4. Reimbursement scenario
    • 10.5.4.5. India cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.5. South Korea
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. Competitive scenario
    • 10.5.5.3. Regulatory framework
    • 10.5.5.4. Reimbursement scenario
    • 10.5.5.5. South Korea cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.6. Australia
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Competitive scenario
    • 10.5.6.3. Regulatory framework
    • 10.5.6.4. Reimbursement scenario
    • 10.5.6.5. Australia cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.7. Thailand
    • 10.5.7.1. Key country dynamics
    • 10.5.7.2. Competitive scenario
    • 10.5.7.3. Regulatory framework
    • 10.5.7.4. Reimbursement scenario
    • 10.5.7.5. Thailand cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.6. Latin America
  • 10.6.1. Latin America cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.6.2. Brazil
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Competitive scenario
    • 10.6.2.3. Regulatory framework
    • 10.6.2.4. Reimbursement scenario
    • 10.6.2.5. Brazil cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.6.3. Argentina
    • 10.6.3.1. Key country dynamics
    • 10.6.3.2. Competitive scenario
    • 10.6.3.3. Regulatory framework
    • 10.6.3.4. Reimbursement scenario
    • 10.6.3.5. Argentina cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.7. Middle East and Africa
  • 10.7.1. Middle East and Africa cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.2. South Africa
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Competitive scenario
    • 10.7.2.3. Regulatory framework
    • 10.7.2.4. Reimbursement scenario
    • 10.7.2.5. South Africa cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.3. Saudi Arabia
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. Competitive scenario
    • 10.7.3.3. Regulatory framework
    • 10.7.3.4. Reimbursement scenario
    • 10.7.3.5. Saudi Arabia cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.4. UAE
    • 10.7.4.1. Key country dynamics
    • 10.7.4.2. Competitive scenario
    • 10.7.4.3. Regulatory framework
    • 10.7.4.4. Reimbursement scenario
    • 10.7.4.5. UAE cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.5. Kuwait
    • 10.7.5.1. Key country dynamics
    • 10.7.5.2. Competitive scenario
    • 10.7.5.3. Regulatory framework
    • 10.7.5.4. Reimbursement scenario
    • 10.7.5.5. Kuwait cardiac cannula market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis by Key Market Participants
• 11.2. Company Categorization
• 11.3. Company Market Share Analysis, 2025
• 11.4. Company Heat Map Analysis
• 11.5. Strategy Mapping
  • 11.5.1. Expansion
  • 11.5.2. Mergers & Acquisition
  • 11.5.3. Partnerships & Collaborations
  • 11.5.4. New Product Launches
  • 11.5.5. Research And Development
  • 11.5.6. Company Profiles
  • 11.5.7. Medtronic
    • 11.5.7.1. Company overview
    • 11.5.7.2. Financial performance
    • 11.5.7.3. Product Benchmarking
    • 11.5.7.4. Strategic initiatives
  • 11.5.8. Edwards Lifesciences Corporation
    • 11.5.8.1. Company overview
    • 11.5.8.2. Financial performance
    • 11.5.8.3. Product Benchmarking
    • 11.5.8.4. Strategic initiatives
  • 11.5.9. Braile Biomedica
    • 11.5.9.1. Company overview
    • 11.5.9.2. Financial performance
    • 11.5.9.3. Product Benchmarking
    • 11.5.9.4. Strategic initiatives
  • 11.5.10. BD (Becton, Dickinson & Corporation)
    • 11.5.10.1. Company overview
    • 11.5.10.2. Financial performance
    • 11.5.10.3. Product Benchmarking
    • 11.5.10.4. Strategic initiatives
  • 11.5.11. Surge Cardiovascular
    • 11.5.11.1. Company overview
    • 11.5.11.2. Financial performance
    • 11.5.11.3. Product Benchmarking
    • 11.5.11.4. Strategic initiatives
  • 11.5.12. LivaNova PLC
    • 11.5.12.1. v Company overview
    • 11.5.12.2. Financial performance
    • 11.5.12.3. Product Benchmarking
    • 11.5.12.4. Strategic initiatives
  • 11.5.13. Getinge
    • 11.5.13.1. Company overview
    • 11.5.13.2. Financial performance
    • 11.5.13.3. Product Benchmarking
    • 11.5.13.4. Strategic initiatives
  • 11.5.14. EUROSETS
    • 11.5.14.1. Company overview
    • 11.5.14.2. Financial performance
    • 11.5.14.3. Product Benchmarking
    • 11.5.14.4. Strategic initiatives
  • 11.5.15. INVAMED
    • 11.5.15.1. Company overview
    • 11.5.15.2. Financial performance
    • 11.5.15.3. Product Benchmarking
    • 11.5.15.4. Strategic initiatives
  • 11.5.16. Cardinal Health
    • 11.5.16.1. Company overview
    • 11.5.16.2. Financial performance
    • 11.5.16.3. Product Benchmarking
    • 11.5.16.4. Strategic initiatives
  • 11.5.17. Andocor
    • 11.5.17.1. Company overview
    • 11.5.17.2. Financial performance
    • 11.5.17.3. Product Benchmarking
    • 11.5.17.4. Strategic initiatives
  • 11.5.18. Xenios AG (Fresenius Medical Care)
    • 11.5.18.1. Company overview
    • 11.5.18.2. Financial performance
    • 11.5.18.3. Product Benchmarking
    • 11.5.18.4. Strategic initiatives
  • 11.5.19. MERA (Senko Medical Instrument Mfg. Co., Ltd.)
    • 11.5.19.1. Company overview
    • 11.5.19.2. Financial performance
    • 11.5.19.3. Product Benchmarking
    • 11.5.19.4. Strategic initiatives
  • 11.5.20. Prymax Healthcare LLP
    • 11.5.20.1. Company overview
    • 11.5.20.2. Financial performance
    • 11.5.20.3. Product Benchmarking
    • 11.5.20.4. Strategic initiatives
  • 11.5.21. Vitalcor, Inc.
    • 11.5.21.1. Company overview
    • 11.5.21.2. Financial performance
    • 11.5.21.3. Product Benchmarking
    • 11.5.21.4. Strategic initiatives
  • 11.5.22. Cormed Medizintechnik GmbH & Co. KG
    • 11.5.22.1. Company overview
    • 11.5.22.2. Financial performance
    • 11.5.22.3. Product Benchmarking
    • 11.5.22.4. Strategic initiatives
  • 11.5.23. Smartcanula LLC
    • 11.5.23.1. Company overview
    • 11.5.23.2. Financial performance
    • 11.5.23.3. Product Benchmarking
    • 11.5.23.4. Strategic initiatives
  • 11.5.24. Changzhou KangXin Medical Instruments Co., Ltd.
    • 11.5.24.1. Company overview
    • 11.5.24.2. Financial performance
    • 11.5.24.3. Product Benchmarking
    • 11.5.24.4. Strategic initiatives
  • 11.5.25. NIPRO
    • 11.5.25.1. Company overview
    • 11.5.25.2. Financial performance
    • 11.5.25.3. Product Benchmarking
    • 11.5.25.4. Strategic initiatives
  • 11.5.26. Spectrum Medical
    • 11.5.26.1. Company overview
    • 11.5.26.2. Financial performance
    • 11.5.26.3. Product Benchmarking
    • 11.5.26.4. Strategic initiatives